Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nilotinib for CMV Reactivation in Allo-HSCT
NCT01252017Phase 2Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Nov 2010
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nilotinib in cytomegalovirus infection (CMV), sponsored by National Taiwan University Hospital. Started Nov 2010; status: completed.
02
Drugs
nilotinib
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT01252017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01252017.